Publications

5443 Results

Current Cancer and Leukemia Group B (CALGB) trials in the treatment of active hairy cell leukemia (HCL): A status report.

Authors
K Rai;R Mick;H Ozer;CD Bloomfield
Journal / Conference
Proc of the Fourth Intl Symp on Therapy of Acute Leukemias-Rome :250(233)
Year
1987
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8694 (CALGB-8582) (NSC-377523) (NSC-218321)

Effect of age on therapeutic outcome in advanced diffusehistiocytic lymphoma: the Southwest Oncology Group experience.

Authors
DO Dixon;BA Neilan;SE Jones;DA Lipschitz;TP Miller;SE Salmon;PN Grozea;SP Balcerzak
Journal / Conference
JCO 4(3):296-305
Year
1986
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427, SWOG-7713/14

What should be the morphologic criteria for the subdivision offollicular lymphomas?

Authors
BN Nathwani;GE Metter;TP Miller;JS Burke;RB Mann;M Barcos;CR Kjeldsberg;DO Dixon;CD Winberg;CC Whitcomb;SE Jones
Journal / Conference
Blood 68(4):837-845
Year
1986
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427, SWOG-7713/14

Therapy of recurrent squamous cell carcinoma of the head and neckusing combination vincristine, bleomycin, and methotrexate.

Authors
RE Smith;LK Heilbrun;RM Bottomly;N Gad-El-Mawla;W Fletcher
Journal / Conference
Cancer 58:2382-2385
Year
1986
Study Number(s)
SWOG-7517

Randomized comparisons of radiotherapy and carmustine versusprocarbazine versus dacarbazine for the treatment of malignant gliomasfollowing surgery: A Southwest Oncology Group study.

Authors
HJ Eyre;JR Eltringham;EA Gehan;FS Vogel;M Al-Surraf;RW Talley;JJ Costanzi;JW Athens;N Oishi;WS Fletcher
Journal / Conference
Cancer Treat Rep 7(9):1085-1090
Year
1986
Research Committee(s)
Brain
Study Number(s)
SWOG-7703

Chemotherapy of drug resistant ovarian cancer. A SouthwestOncology Group study.

Authors
LR Laufman;JB Green;DS Alberts;RB O'Toole;RD Hilgers;DC Young;P Lin;SE Rivkin
Journal / Conference
JCO 4(9):1374-1379
Year
1986
Study Number(s)
SWOG-7706

A usefull high-dose intermittent schedule of adriamycin and DTICin the treatment of advanced sarcomas:

Authors
JH Saiki;LH Baker;SE Rivkin;S Shahbender;WS Fletcher;JW Athens;SP Balcerzak;JD Bonnet
Journal / Conference
Cancer 58(10):2196-2197
Year
1986
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-7765

Improved survival duration with combination chemotherapyinduction for multiple myeloma: A Southwest Oncology Group study.

Authors
BGM Durie;DO Dixon;S Carter;R Stephens;S Rivkin;J Bonnet;SE Salmon;L Dabich;JC Files;JJ Costanzi
Journal / Conference
JCO 4(8):1227-1237
Year
1986
Research Committee(s)
Myeloma
Study Number(s)
SWOG-7927/28

Phase II study of mitoguazone in pancreatic cancer: A SouthwestOncology Group study.

Authors
MS Inamasu;N Oishi;TT Chen;EH Kraut;PN Grozea;JJ Costanzi;JD Bonnet
Journal / Conference
Cancer Treat Rep 70(4):531-532
Year
1986
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7931, SWOG-8042

Effect of alternating combination chemotherapy on survival ofambulatory patients with metastatic large cell and adenocarcinomaof the lung. A Southwest Oncology study.

Authors
TP Miller;TT Chen;RB Livingston;C Coltman, Jr;RM O'Bryan;RB Vance;G Weiss;WS Fletcher;RL Stephens
Journal / Conference
JCO 4(4):502-508
Year
1986
Research Committee(s)
Lung
Study Number(s)
SWOG-8012